WallStreetZenWallStreetZen

NASDAQ: CGEM
Cullinan Therapeutics Inc Stock Ownership - Who owns Cullinan Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cullinan Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jennifer MichaelsonChief Scientific Officer2025-12-191,345$10.01
$13.46kSell
Jacquelyn L. SumerChief Legal Officer2025-12-183,480$9.67
$33.65kSell
Jeffrey Alan JonesChief Medical Officer2025-12-184,632$9.67
$44.79kSell
Jennifer MichaelsonChief Scientific Officer2025-12-182,898$9.67
$28.02kSell
Jennifer MichaelsonChief Scientific Officer2025-12-15995$11.90
$11.84kSell
Jennifer MichaelsonChief Scientific Officer2025-12-122,148$12.38
$26.59kSell
Jennifer MichaelsonChief Scientific Officer2025-11-244,000$12.30
$49.20kSell
Lynx1 Capital Management LP10% Owner2025-10-28165,667$8.40
$1.39MBuy
Lynx1 Capital Management LP10% Owner2025-10-1732,217$7.84
$252.58kBuy
Lynx1 Capital Management LP10% Owner2025-10-16150,000$8.86
$1.33MBuy

1 of 2

CGEM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGEM insiders and whales buy or sell their stock.

CGEM Shareholders

What type of owners hold Cullinan Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ansbert Gadicke27.35%16,157,644$161.58MInsider
Lynx1 Capital Management LP15.17%8,963,500$89.64MInsider
Ubs Oncology Impact Fund LP12.95%7,648,268$76.48MInsider
Mpm Bioimpact LLC12.95%7,648,268$76.48MInstitution
Lynx1 Capital Management LP9.76%5,766,090$57.66MInstitution
Bvf Inc9.73%5,750,683$57.51MInstitution
Morana Jovanembiricos7.84%4,631,022$46.31MInsider
Vision Scs F27.58%4,476,350$44.76MInsider
F2 Bioscience I 2017 Ltd7.50%4,430,964$44.31MInsider
Blackrock Inc7.06%4,169,962$41.70MInstitution

1 of 3

CGEM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGEM55.52%44.48%Net BuyingNet Buying
NBY0.10%99.90%Net Buying
ANRO53.94%21.66%
ANNX78.53%21.47%Net BuyingNet Buying
ENGN61.01%28.37%
View Top Biotech Stocks

Cullinan Therapeutics Stock Ownership FAQ

Who owns Cullinan Therapeutics?

Cullinan Therapeutics (NASDAQ: CGEM) is owned by 103.39% institutional shareholders, 82.84% Cullinan Therapeutics insiders, and 0.00% retail investors. Ansbert Gadicke is the largest individual Cullinan Therapeutics shareholder, owning 16.16M shares representing 27.35% of the company. Ansbert Gadicke's Cullinan Therapeutics shares are currently valued at $165.78M.

If you're new to stock investing, here's how to buy Cullinan Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.